Urinary estrogen metabolites and prostate cancer: a case–control study in the United States
✍ Scribed by Paola Muti; Kim Westerlind; Tiejian Wu; Thomas Grimaldi; John De Berry; Holger Schünemann; Jo L. Freudenheim; Helyn Hill; Giuseppe Carruba; Leon Bradlow
- Book ID
- 110413242
- Publisher
- Springer Netherlands
- Year
- 2002
- Tongue
- English
- Weight
- 107 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0957-5243
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con
The nutritional aetiology of prostate cancer was evaluated in Athens, Greece, through a case-control study that included 320 patients with histologically confirmed incident prostate cancer and 246 controls without history or symptomatology of benign prostatic hyperplasia or prostate cancer, treated